- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-small Cell Lung Cancer (NSCLC) in Poland
Total 911 results
-
PfizerActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Netherlands, Korea, Republic of, Italy
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedNon Small Cell Lung CancerUnited States, Poland, Germany, Russian Federation, Latvia, Ukraine
-
AmgenCompletedSquamous-Cell Non-Small-Cell Lung CancerFrance, Belgium, Spain, United States, Taiwan, Korea, Republic of, Japan, Poland
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerUnited States, Argentina, China, Korea, Republic of
-
NovoCure GmbHActive, not recruitingBrain Metastases From Non-small Cell Lung Cancer (NSCLC)United States, China, Israel, Spain, Austria, Canada, Hong Kong, Germany, France, Bulgaria, Croatia, Hungary, Italy, Poland, Serbia
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, France, Germany, Russian Federation, Poland, Italy
-
SanofiCompletedNon-small Cell Lung CancerFrance, Romania, Poland, Croatia, Korea, Republic of, Italy, Chile, United States, Australia, Germany, Russian Federation, Serbia, Ukraine
-
Ariad PharmaceuticalsTakedaActive, not recruitingALK-positive Advanced NSCLCKorea, Republic of, United States, Spain, Taiwan, Canada, Hong Kong, China, Sweden, Australia, Italy, Japan, Germany, Netherlands, France, Austria
-
Dizal PharmaceuticalsRecruitingNon-small Cell Lung CancerChina, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Germany, Italy, Netherlands, Poland, Spain, Turkey
-
Incyte CorporationZai Lab (Shanghai) Co., Ltd.Active, not recruitingMetastatic Squamous Non-Small Cell Lung Cancer | Metastatic Nonsquamous Non-Small Cell Lung CancerChina, Czechia, Russian Federation, Serbia, Malaysia, Vietnam, United States, Poland, Ukraine, Romania, Turkey, Brazil, Bulgaria, Georgia, Hungary, Philippines, South Africa
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer | Cancer of the Head and NeckPoland, Germany, Hungary, United Kingdom
-
Daiichi Sankyo, Inc.CompletedMetastatic Non-small Cell Lung CancerUnited States, India, Poland, Romania
-
Prestige Biopharma LimitedActive, not recruitingLung Cancer | Non-small Cell Lung CancerIndia, Hungary, Georgia, Philippines, Belarus, Bulgaria, Croatia, Greece, Latvia, Malaysia, Poland, Russian Federation, Serbia, Slovakia, Thailand, Turkey, Ukraine
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung AdenocarcinomaUnited States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
-
Boehringer IngelheimRecruitingSmall Cell Lung Carcinoma (SCLC)United States, United Kingdom, Germany, France, Poland
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Spain, Belgium, France, Germany, Hungary, Italy, United Kingdom, Korea, Republic of, Poland, Australia, Switzerland, Singapore, Netherlands, Romania, Czechia, Greece, Ireland, Austria, Russian Federation, Portugal, Hong... and more
-
Synta Pharmaceuticals Corp.CompletedNon Small Cell Lung CancerUnited States
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerCanada, United States, Korea, Republic of, Israel, Spain, United Kingdom, Belgium, Germany, Netherlands, Hungary, Italy, Czechia, Australia, Austria, Poland, Argentina, Brazil, Bulgaria, Chile, Colombia, France, Georgia, Greece, Ireland, Malays... and more
-
NovoCure GmbHActive, not recruitingNSCLC | Nonsmall Cell Lung CancerUnited States, Poland, Hong Kong, China, Spain, Serbia, Croatia, France, Canada, Netherlands, Austria, Belgium, Bulgaria, Czechia, Germany, Hungary, Italy, Switzerland
-
BioAtla, Inc.RecruitingNon-Small-Cell Lung CancerUnited States, Hong Kong, Taiwan, Spain, Greece, Germany, Italy, Poland
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, France, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerCanada, Brazil, Korea, Republic of, Spain, Argentina, United States, Costa Rica, Chile, Latvia, Finland, Italy, Poland
-
ETOP IBCSG Partners FoundationEuropean Organisation for Research and Treatment of Cancer - EORTC; AmgenTerminatedLung Cancer Non-small Cell Stage IVIreland, Spain, Switzerland, United Kingdom, France, Austria, Slovenia, Belgium, Italy, Germany, Poland
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Non-squamous Non-small-cell Lung Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | KEAP1 Gene Mutation | NFE2L2 Gene Mutation | NRF2 MutationUnited States
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, Italy, France, Germany
-
Heat BiologicsTerminatedNon Small Cell Lung CancerUnited States
-
Xcovery Holding Company, LLCCompletedAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Canada, Austria, Finland, France, Greece, Korea, Republic of, Panama, Portugal, Spain, Turkey, United Kingdom, Taiwan, Brazil, Germany, Poland, Chile, Guatemala, Russian Federation, Switzerland, Thailand, Ukraine, Serb... and more
-
ArdigenNational Center for Research and Development, PolandUnknownMelanoma | Non Small Cell Lung Cancer | Metagenome | Immunotherapy | MicrobiomePoland
-
National Cancer Institute (NCI)Active, not recruitingLung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Puerto Rico
-
Spanish Lung Cancer GroupTerminated
-
Brown UniversityRhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedA Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)Non-Small Cell Lung CancerUnited States
-
Shanghai Henlius BiotechActive, not recruitingSquamous Non Small Cell Lung CancerChina, Turkey, United States, Georgia, Poland, Russian Federation, Ukraine
-
Daiichi SankyoAvailableEpidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedStage IIIB Non-Small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellGermany, United Kingdom, Italy, Poland
-
Threshold PharmaceuticalsEMD SeronoTerminatedNon-small Cell Lung CancerUnited States, Germany, Spain, Poland, Greece, Czechia, Hungary, Italy, Romania, Russian Federation
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States, Italy, Australia, Poland, Spain
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLS With Exon 20 Insertion MutationUnited States, Spain, Canada, Italy, Israel, Japan, United Kingdom, Korea, Republic of, Germany, France, Turkey, Belgium, Netherlands, Philippines, Poland, Singapore
-
Eli Lilly and CompanyCompletedA Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung CancerNon-Small Cell Lung Cancer Stage IVUnited States, Italy, Spain, Australia, France, Germany, Hungary, Korea, Republic of, Poland, Romania, Russian Federation, Taiwan, Ukraine
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerUnited States, Canada
-
Geron CorporationCompletedNon-small Cell Lung CancerUnited States, Canada, Germany
-
European Organisation for Research and Treatment...CompletedLung CancerItaly, South Africa, United Kingdom, Netherlands, Poland
-
Samsung Bioepis Co., Ltd.CompletedA Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung CancerLung Cancer | Non-small Cell Lung CancerKorea, Republic of, Germany, Hungary, Taiwan, Thailand, Georgia, Serbia, Poland, Romania, Ukraine, Spain, Belarus, Russian Federation
-
Angela Taber MDThe Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode Island; Roger...TerminatedNon-Small Cell Lung CancerUnited States
-
Eli Lilly and CompanyCompleted